Esperion Therapeutics
Gina Pazdan Deignan currently serves as the Vice President of Quality at Esperion, a position held since July 2023. Prior to this role, Gina held senior leadership positions in quality systems at Pfizer and Global Blood Therapeutics following Pfizer's acquisition of GBT in October 2022. Previous experience includes serving as Senior Director of Quality Management Systems at Portola Pharmaceuticals until its acquisition by Alexion, and a decade at Genentech in various quality management roles. Earlier career experience includes business development at deCODE chemistry & biostructures and research at MediChem Research. Gina holds a Bachelor of Science in Chemistry from the University of Illinois Urbana-Champaign.
This person is not in any teams
This person is not in any offices